Senior insider sale
EVP, Reg. Strategy, Clinical at DEXCOM INC — senior position signals high conviction
$642.2K
4.94K shares
What this filing means
BALO ANDREW K plans to sell 4.94K shares of DEXCOM INC valued at approximately $642.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2023ACC: 0001950047-23-001705
Officer· EVP, Reg. Strategy, Clinical
Since Jul 2018
4.94K
Shares to sell
$642.2K
Approx. market value
4.94K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
9/8/2021
4.94KTotal acquired4.94K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2021 | Restricted Stock Not Applicable | 4.94K | — |
| Total | 4.94K | ||
Planned & Completed Dispositions1
NASDPlanned
Units to sell
4.94K
Market value
$642.2K
6/15/2023
Total
Units
4.94K
Value
$642.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/15/2023 | 4.94K | $642.2K | NASD | Planned |
| Total | 4.94K | $642.2K | ||